ClassID:

20505

A61K31/683 - page 2 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Phosphorus compounds Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols

Recent Application in this class:
#301
20160095888
2016-04-07

Method of reducing appetite in a human subject comprising administering krill oil composition

#302
20160067295
2016-03-10

WALNUT EXTRACTS FOR NUTRACEUTICAL APPLICATIONS

#303
20160051504
2016-02-25

Composition for external use on skin for inflammatory diseases

#304
20160038515
2016-02-11

Methods and compositions for enhancing oxygen levels in tissues

#305
20160015713
2016-01-21

Modulators of toll-like receptors

#306
20160008393
2016-01-14

Methods for the treatment of hepatitis B and hepatitis D virus infections

#307
20150376213
2015-12-31

Phospholipid compound containing unsaturated fatty acid derivative having cyclopropane ring

#308
20150361088
2015-12-17

Two-carbon linked artemisinin-derived trioxane dimers

#309
20150343063
2015-12-03

Protective effect of DMPC, DMPG, DMPC/DMPG, EGPG, LysoPG and LysoPC against drugs that cause channelopathies

#310
20150343027
2015-12-03

Hypotonic aqueous composition with reduced chloride content, with or without phospholipids

#311
20150342971
2015-12-03

Sphingomyelin-containing supplement

#312
20150335716
2015-11-26

Flavored chewable lipid supplements for maintaining health and the treatment of acute and chronic disorders

#313
20150327586
2015-11-19

Non-medical increase or maintenance of body weight of a mammal

#314
20150313853
2015-11-05

Anti-HIV compound and preparation method and use thereof

#315
20150307450
2015-10-29

Derivatives of indole for the treatment of cancer, viral infections and lung diseases

#316
20150297524
2015-10-22

Lyophilization of synthetic liposomal pulmonary surfactant

#317
20150272972
2015-10-01

Inhibition of HIV infection through chemoprophyalxis

#318
20150272971
2015-10-01

Use of glycerophosphoinositols for the treatment of septic shock

#319
20150265636
2015-09-24

Compositions and methods for treating addiction

#320
20150239921
2015-08-27

Phosphonate compounds for treatment of complement mediated disorders

#321
20150239920
2015-08-27

Ether compounds for treatment of complement mediated disorders

#322
20150239919
2015-08-27

Carbamate, ester, and ketone compounds for treatment of complement mediated disorders

#323
20150239895
2015-08-27

Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders

#324
20150239894
2015-08-27

Amino compounds for treatment of complement mediated disorders

#325
20150239893
2015-08-27

Amide compounds for treatment of complement mediated disorders

#326
20150239868
2015-08-27

Alkyne compounds for treatment of complement mediated disorders

#327
20150239838
2015-08-27

Compounds for treatment of complement mediated disorders

#328
20150239837
2015-08-27

Factor D inhibitors useful for treating inflammatory disorders

#329
20150224075
2015-08-13

OMEGA 3 FORMULATIONS FOR TREATMENT OF RISK FACTORS FOR CARDIOVASCULAR DISEASE AND PROTECTION AGAINST SUDDEN DEATH

#330
20150216873
2015-08-06

Methods of treating patients co-infected with HIV and tuberculosis

#331
20150209397
2015-07-30

METHODS AND MATERIALS FOR REDUCING RETICULOENDOTHELIAL SYSTEM CLEARANCE OF PARTICLES FROM A SUBJECT

#332
20150196581
2015-07-16

Compositions for external application, containing adenosylcobalamin for improvement of skin diseases

#333
20150174147
2015-06-25

Unitary pharmaceutical dosage form

#334
20150157669
2015-06-11

Bioeffective krill oil compositions

#335
20150150893
2015-06-04

ANDROGRAPHOLIDE ANALOGS AND THEIR USE FOR MEDICATION

#336
20150150891
2015-06-04

Surfactant lipids, compositions thereof, and uses thereof

#337
20150148316
2015-05-28

LIPID MIXTURE FOR INFANT NUTRITION

#338
20150111856
2015-04-23

Compositions and methods for combination antiviral therapy

#339
20150111855
2015-04-23

Compositions and methods for combination antiviral therapy

#340
20150099722
2015-04-09

6-oxopurine phosphoribosyltransferase inhibitors

#341
20150071884
2015-03-12

Nutrition Composition

#342
20150057252
2015-02-26

Pharmaceutical composition and use of diethyl (2-cyanoethyl)phosphonate

#343
20150057249
2015-02-26

Vesicular formulations

#344
20150038472
2015-02-05

USE OF THERAPEUTICALLY EFFECTIVE LIPIDS AND METHOD FOR PRODUCING ORGAN-/TISSUE-SPECIFIC THERAPEUTICALLY EFFECTIVE LIPIDS

#345
20150018570
2015-01-15

Lipid compositions with high DHA content

#346
20150018314
2015-01-15

Benzimidazolium compounds

#347
20150018313
2015-01-15

5-substituted benzimidazolium compounds

#348
20150011520
2015-01-08

Pharmaceutical compositions to reduce complications of ocular steroid

#349
20150004227
2015-01-01

Bioeffective krill oil compositions

#350
20150004223
2015-01-01

Bioeffective krill oil compositions

#351
20140370102
2014-12-18

METHOD AND COMPOSITION FOR PHARMACEUTICAL PRODUCT

#352
20140364400
2014-12-11

Esters for treatment of ocular inflammatory conditions

#353
20140328909
2014-11-06

KRILL OIL AND REACTED ASTAXANTHIN COMPOSITION AND ASSOCIATED METHOD

#354
20140316132
2014-10-23

Modulators of toll-like receptors

#355
20140309190
2014-10-16

Bicyclic aryl sphingosine 1-phosphate analogs

#356
20140308345
2014-10-16

Krill oil and reacted astaxanthin composition and associated method

#357
20140275251
2014-09-18

Composition for external use on skin for inflammatory diseases

#358
20140274938
2014-09-18

Improving recognition

#359
20140274922
2014-09-18

ALGAL OMEGA 7 COMPOSITIONS

#360
20140271706
2014-09-18

Compositions and methods for utilization of algal compounds

#361
20140256681
2014-09-11

Co-administration of steroids and zoledronic acid to prevent and treat osteoarthritis

#362
20140213556
2014-07-31

COMPOSITIONS AND METHODS FOR COMBINATION ANTIVIRAL THERAPY

#363
20140199414
2014-07-17

KRILL AND/OR MARINE EXTRACTS FOR PREVENTION AND/OR TREATMENT OF CARDIOVASCULAR DISEASES, ARTHRITIS, SKIN CANCER, DIABETES, PREMENSTRUAL SYNDROME AND TRANSDERMAL TRANSPORT

#364
20140186406
2014-07-03

Treatment of Infection

#365
20140141074
2014-05-22

Concentrated therapeutic phospholipid compositions

#366
20140134228
2014-05-15

Chewable wafers containing lipid supplements for maintaining health and the treatment of acute and chronic disorders

#367
20140120171
2014-05-01

Therapeutic application of parenteral krill oil

#368
20140107080
2014-04-17

BRAIN FUNCTION IMPROVING AGENT

#369
20140088026
2014-03-27

Lyophilization of synthetic liposomal pulmonary surfactant

#370
20140088025
2014-03-27

Lyophilization of synthetic liposomal pulmonary surfactant

#371
20140051103
2014-02-20

Procedure for biphasic preparation of liposomes and application thereof in manufacturing diagnostic reagents

#372
20140038921
2014-02-06

Low side effect pharmaceutical composition containing antituberculosis drugs

#373
20140037724
2014-02-06

Unitary pharmaceutical dosage form

#374
20140010888
2014-01-09

Bioeffective krill oil compositions

#375
20140005421
2014-01-02

Methods for producing bioeffective krill oil compositions

#376
20140005144
2014-01-02

NOVEL LEUKOTRIENE RECEPTOR ANTAGONIST

#377
20130337041
2013-12-19

CHARGED PHOSPHOLIPID COMPOSITIONS AND METHODS FOR THEIR USE

#378
20130330424
2013-12-12

Non-medical increase or maintenance of body weight of a mammal

#379
20130316983
2013-11-28

DRUG SCREENING METHOD, COMPOSITIONS AND METHODS OF TREATING GLAUCOMA

#380
20130302280
2013-11-14

Inhibitors of flaviviridae viruses

#381
20130295171
2013-11-07

KRILL OIL AND REACTED ASTAXANTHIN COMPOSITION AND ASSOCIATED METHOD

#382
20130295075
2013-11-07

COMPOSITIONS AND METHODS OF TREATING GLAUCOMA

#383
20130280340
2013-10-24

Compositions and methods of using lamellar bodies for modifying linear biological macromolecules

#384
20130225532
2013-08-29

Zanamivir phosphonate congeners with anti-influenza activity and determining oseltamivir susceptibility of influenza viruses

#385
20130225531
2013-08-29

METHOD AND COMPOSITION FOR TREATING ALZHEIMER'S DISEASE AND DEMENTIAS OF VASCULAR ORIGIN

#386
20130225525
2013-08-29

Combined Treatment Utilizing VB-201

#387
20130217654
2013-08-22

Surfactant lipids, compositions thereof, and uses thereof

#388
20130172286
2013-07-04

Functional Food Supplement Intended, In Particular, For Nutrition And For Prevention And Improvement of Neurological Alterations, Neurodegenerative Alterations Or Cognitive Disorders

#389
20130157981
2013-06-20

Substituted pyrazines and their use in the treatment of disease

#390
20130157978
2013-06-20

Preparation for the prevention and/or treatment of vascular disorders

#391
20130157967
2013-06-20

Method for the removal of subcutaneous fat accumulations by subcutaneous lipolysis by administering a combination of glycyrrhizic acid and soybean phospholipids

#392
20130109654
2013-05-02

Anti-cytomegalovirus activity of artemisinin-derived dimers

#393
20130101629
2013-04-25

Homogenous suspension of immunopotentiating compounds and uses thereof

#394
20130071446
2013-03-21

Infant nutrition for improving fatty acid composition of brain membranes

#395
20130071354
2013-03-21

Modulators of toll-like receptors

#396
20130059768
2013-03-07

Lipid compositions with high DHA content

#397
20130028959
2013-01-31

Liposomes for Preventing the Spread of HIV

#398
20130005805
2013-01-03

Esters for treatment of ocular inflammatory conditions

#399
20130005691
2013-01-03

Esters for treatment of ocular inflammatory conditions

#400
20120329758
2012-12-27

Combined Treatment Utilizing VB-201

#401
20120322769
2012-12-20

Methods of reducing virulence in bacteria

#402
20120321602
2012-12-20

Omega-3 fatty acid nutriceutical composition and optimization method

#403
20120321586
2012-12-20

Surfactant composition

#404
20120302639
2012-11-29

OMEGA 3 FORMULATIONS FOR TREATMENT OF RISK FACTORS FOR CARDIOVASCULAR DISEASE AND PROTECTION AGAINST SUDDEN DEATH

#405
20120277196
2012-11-01

Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications

#406
20120270842
2012-10-25

Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof

#407
20120232034
2012-09-13

VESICULAR FORMULATIONS

#408
20120190649
2012-07-26

Bicyclic aryl sphingosine 1-phosphate analogs

#409
20120177732
2012-07-12

CONCENTRATION AND MENTAL PERFORMANCE AMPLIFYING FORMULATION

#410
20120156280
2012-06-21

Myeloid derived suppressor cell inhibiting agents

#411
20120156166
2012-06-21

Inhibitors of viruses

#412
20120143074
2012-06-07

METHOD OF EVALUATING SUITABILITY FOR DRUG THERAPY FOR THE PREVENTION AND TREATMENT OF ANXIETY DISORDERS USING CHOLINERGIC TYPE II THETA RHYTHM

#413
20120141594
2012-06-07

Composition with anti-inflammatory, protein synthesizing, treatment of enzyme deficiency, activating genetic therapy and anti-cancer activity and methods of use

#414
20120065172
2012-03-15

Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications

#415
20120058149
2012-03-08

TREATMENT OF INFECTION

#416
20120040014
2012-02-16

Lipid supplements for maintaining health and treatment of acute and chronic disorders

#417
20120028922
2012-02-02

Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications

#418
20120021982
2012-01-26

PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF LEFT VENTRICULAR DIASTOLIC DYSFUNCTION

#419
20110305771
2011-12-15

Krill Extracts for Treatment of Cardiovascular Diseases

#420
20110268787
2011-11-03

Ocular compositions containing dioleoylphosphatidylglycerol and uses thereof

#421
20110257132
2011-10-20

CHARGED PHOSPHOLIPID COMPOSITIONS AND METHODS FOR THEIR USE

#422
20110223246
2011-09-15

DOCOSAHEXAENOIC ACID BOUND IN PHOSPHOLIPIDS AND METHOD OF RECOVERING SAME FROM A NATURAL SOURCE

#423
20110217411
2011-09-08

Nutritional compositions with coated lipid globules

#424
20110212924
2011-09-01

Compositions and methods to treat cardiac diseases

#425
20110212541
2011-09-01

COMPOSITIONS AND METHODS TO PROTECT CELLS BY BLOCKING ENTRY OF PATHOGEN PROTEINS

#426
20110206743
2011-08-25

Nutritional compositions with lipid globules with a core comprising vegetable lipids and a coating comprising phospholipids or polar lipids

#427
20110160161
2011-06-30

Concentrated therapeutic phospholipid compositions

#428
20110104297
2011-05-05

Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders

#429
20110098254
2011-04-28

COMPOSITIONS COMPRISING PHOSPHOLIPIDS

#430
20110092430
2011-04-21

METHOD AND COMPOUND FOR THE TREATMENT OF VALVULAR DISEASE

#431
20110065673
2011-03-17

NOVEL LEUKOTRIENE RECEPTOR AGONIST

#432
20110059158
2011-03-10

CHARGED PHOSPHOLIPID COMPOSITIONS AND METHODS FOR THEIR USE

#433
20110034415
2011-02-10

WALNUT EXTRACTS FOR NUTRACEUTICAL APPLICATIONS

#434
20110003775
2011-01-06

Composition and method for promoting survival of aged basal forebrain cholinergic neuron leading to provention and treatment of age-related neurodegenerative disorder

#435
20100331280
2010-12-30

Modulation of the Phospholipase A2 Pathway as a Therapeutic

#436
20100323030
2010-12-23

Composition with anti-inflammatory, protein synthesizing, enzyme deficiency activating genetic therapy and anti-cancer activity and methods of use

#437
20100303784
2010-12-02

Preparation for the prevention and/or treatment of vascular disorders

#438
20100298273
2010-11-25

Lipid mixture for infant nutrition

#439
20100267846
2010-10-21

Molecular delivery vehicle

#440
20100266678
2010-10-21

Cholesterol level lowering liposomes

#441
20100233304
2010-09-16

COMPOSITIONS COMPRISING UNSATURATED FATTY ACIDS AND NITRIC OXIDE RELEASING COMPOUNDS AND USE THEREOF FOR ENHANCING COGNITIVE AND RELATED FUNCTIONS

#442
20100221251
2010-09-02

Compositions and methods for treatment of cancer

#443
20100210590
2010-08-19

COMPOSITIONS AND TREATMENTS FOR SEIZURE-RELATED DISORDERS

#444
20100196586
2010-08-05

FOODSTUFF COMPOSITION TO IMPROVE DIGESTIBILITY OF FOODSTUFF LIPIDS

#445
20100184725
2010-07-22

Method and Composition for Treating Alzheimer's Disease and Dementias of Vascular Origin

#446
20100173872
2010-07-08

Method and Composition for Treating Alzheimer's Disease and Dementias of Vascular Origin

#447
20100143301
2010-06-10

Modulators of toll-like receptors

#448
20100061969
2010-03-11

DIETARY SUPPLEMENT, ANTI-FATIGUE AGENT OR PHYSICAL ENDURANCE ENHANCER, FUNCTIONAL FOOD, OR COSMETIC

#449
20100041751
2010-02-18

Method to Reduce Oxidative Damage and Improve Mitochondrial Efficiency

#450
20100029590
2010-02-04

METHODS FOR TREATING OR PREVENTING HEMORRHAGIC CYSTITIS USING A GLYCEROPHOSPHATE SALT

#451
20090232879
2009-09-17

Thyromimetics for the Treatment of Fatty Liver Diseases

#452
20090202470
2009-08-13

Phosphonate analogs of HIV inhibitor compounds

#453
20090186808
2009-07-23

Method for the treatment of valvular disease

#454
20090176741
2009-07-09

MODULATION OF THE IMMUNE SYSTEM BY INOSITOL PHOSPHOLIPIDS

#455
20090143314
2009-06-04

Compositions and methods for combination antiviral therapy

#456
20090111773
2009-04-30

Compositions and methods of using lamellar bodies for modifying linear biological macromolecules

#457
20090060876
2009-03-05

Method of using compatible solutes containing ectoine and/or hydroxyectoine

#458
20090042840
2009-02-12

Phospholipids for Use in the Treatment of an Allergic Inflammatory Condition

#459
20090036410
2009-02-05

Structured Phospholipids

#460
20090036408
2009-02-05

Compositions and methods for combination antiviral therapy

#461
20090036354
2009-02-05

Carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof

#462
20090029950
2009-01-29

Composition for reducing the exudation of serum proteins

#463
20090012037
2009-01-08

Antiviral compounds

#464
20080318909
2008-12-25

Use Of Linoleic Compounds Against Heart Failure

#465
20080312187
2008-12-18

PHOSPHOINOSITIDE MODULATION FOR THE TREATMENT OF ALZHEIMER'S DISEASE

#466
20080286377
2008-11-20

ANTI-RESORPTIVE BONE CEMENTS AND ALLOGENEIC, AUTOGRAFIC, AND XENOGRAFIC BONE GRAFTS

#467
20080275007
2008-11-06

CHARGED PHOSPHOLIPID COMPOSITIONS AND METHODS FOR THEIR USE

#468
20080274203
2008-11-06

Bioeffective krill oil compositions

#469
20080242640
2008-10-02

Surfactant lipids, compositions thereof and uses thereof

#470
20080193561
2008-08-14

Preparation for the prevention and/or treatment of vascular disorders

#471
20080171082
2008-07-17

PHARMACEUTICALLY ACCEPTABLE PHOSPHATE-GLYCEROL CARRYING BODIES

#472
20080171081
2008-07-17

PHARMACEUTICALLY ACCEPTABLE PHOSPHATE-GLYCEROL CARRYING BODIES

#473
20080166401
2008-07-10

Use of therapeutically effective lipids and method for producing organ-/tissue-specific therapeutically effective lipids

#474
20080166400
2008-07-10

PHARMACEUTICALLY ACCEPTABLE PHOSPHATE-GLYCEROL CARRYING BODIES

#475
20080160074
2008-07-03

PHARMACEUTICALLY ACCEPTABLE PHOSPHATE-GLYCEROL CARRYING BODIES

#476
20080138393
2008-06-12

Water soluble extract of spinach for prevention and repair of DNA damage

#477
20080125400
2008-05-29

USE OF PHOSPHOENOLPYRUVATE DERIVATIVES

#478
20080075764
2008-03-27

PHARMACEUTICALLY ACCEPTABLE PHOSPHATE-GLYCEROL CARRYING BODIES

#479
20080019926
2008-01-24

Lung Surfactant Supplements

#480
20070265227
2007-11-15

Inhibition of HIV infection through chemoprophylaxis

#481
20070202194
2007-08-30

Preparation for the prevention and/or treatment of vascular disorders

#482
20070135376
2007-06-14

METHOD TO REDUCE OXIDATIVE DAMAGE AND IMPROVE MITOCHONDRIAL EFFICIENCY

#483
20070122464
2007-05-31

Use of osmolytes obtained from extremophilic bacteria for producing medicine for the external treatment of neurodermatitis

#484
20070122452
2007-05-31

Fat composition

#485
20070099902
2007-05-03

Unitary pharmaceutical dosage form

#486
20070098808
2007-05-03

Krill extracts for treatment of cardiovascular diseases

#487
20070077295
2007-04-05

Method and composition for pharmaceutical product

#488
20070071805
2007-03-29

Treatment of inflammation and vascular abnormalities of the eye

#489
20070049754
2007-03-01

Phosphonate analogs of HIV inhibitor compounds

#490
20070009590
2007-01-11

Physiologically active composition based on phosphatidylserine

#491
20060286181
2006-12-21

Diet supplements for causing fast weight loss, improving daytime energy, promoting nighttime relaxation and sleep, controlling appetite and/or increasing metabolism

#492
20060286038
2006-12-21

Pulmonary surfactant formulations

#493
20060275356
2006-12-07

Pharmaceutical compositions for treating or preventing coronary artery disease

#494
20060246130
2006-11-02

Compositions and methods for combination antiviral therapy

#495
20060246124
2006-11-02

Methods of treating cancer with lipid-based platinum compound formulations administered intraperitoneally

#496
20060234982
2006-10-19

Compositions and methods for combination antiviral therapy

#497
20060223760
2006-10-05

Compositions and methods for treatment of cancer

#498
20060199956
2006-09-07

Bicyclic heterocycles as HIV integrase inhibitors

#499
20060128656
2006-06-15

Charged phospholipid compositions and methods for their use

#500
20060105032
2006-05-18

Multiple sclerosis treatment

#501
20060105031
2006-05-18

Accelerating recovery from trauma

#502
20060078574
2006-04-13

Purified phospholipid-non-steroidal anti-inflammatory drug associated compositions and methods for preparing and using same

#503
20050183146
2005-08-18

Inhibitors of the inositol polyphosphate 5-phosphatase SHIP2 molecule

#504
20050164981
2005-07-28

Biological lubricant composition and method of applying lubricant composition

#505
20050147660
2005-07-07

Peptide-carrying bodies for immune response

#506
20050080051
2005-04-14

Charged phospholipid compositions and methods for their use

#507
20050070877
2005-03-31

Compositions and methods of using lamellar bodies for modifying linear biological macromolecules

#508
20050058698
2005-03-17

Pharmaceutically acceptable phosphate-glycerol carrying bodies and uses relating to Parkinson's Disease

#509
20050020542
2005-01-27

Method of modulating sodium ion absorption in epithelial cells

#510
17994014
2024-01-30

Algal botanical extracts rich in eicosapentaenoic acid as tri/di-glyceride conjugate

#511
16658099
2022-03-08

Omega-3 fatty acid nutriceutical compositions and methods

#512
15651648
2019-02-12

Composition of natural products for improved brain functioning

#513
14251632
2017-04-04

Omega-3 fatty acid nutriceutical composition and optimization method